FDA Approves Drug To Treat Rare Disorder

Posted on

According to news sources, The Food and Drug Administration has recently approved the first drug aimed at treating a rare kind of bone marrow disorder that causes a build up of red blood cells in the bone marrow.

The drug comes in the form of a pill and is taken twice daily to treat myelofibrosis. Approved as part of the FDA’s new priority review program, which attempts to expedite the review duration of newer drugs, the drug was cleared Wednesday to enter the market.

Drug makers Incyte Corp., introduced the new pill called Jakafi, after two studies involving 528 people with the disease found that those who took the new drug experienced a significant reduction in the symptoms associated with the disorder.

The company reportedly estimates that there are anywhere between 16,000 to 18,500 people in the U.S thought to have the rare disorder.

The disorder is currently being treated with either chemotherapy or a bone marrow transplant.

As a personal injury lawyer Los Angeles, I’m glad to see that research is continually being conducted to provide safer and more advanced drugs for those with rare diseases. I hope patients will find the conclusions of this study useful. If you or someone you care about has been injured or suffered from the use of an unsafe product, I recommend you contact a product liability lawyer Los Angeles as soon as possible.